drugset / Trial / NCT02304705
Sildenafil in Heart Failure With Reactive Pulmonary Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Sildenafil 20mg taken three times a day is effective in the treatment of Heart Failure with Reactive Pulmonary Hypertension. This is a double-blind, placebo controlled trial.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sildenafil | Unknown | 20 mg | Oral |